Pharmaceutical companies, biotech, medical device and genomics, as well as contract research organizations (CROs) and contract manufacturing organizations (CMOs) are our clientele.
India & Life Sciences Market
India ranks 2nd globally in terms of the number of US FDA-certified plants located outside the US. We are one of the fastest growing Life Sciences (LS) markets in the world. The LS sector in the country is poised to see multi-fold growth by 2030 led by fast-increasing population, rising life expectancy, a strong industrial base and government initiatives.The three subsectors of the Indian LS sector are expected to witness an accelerated growth in the coming years led by various factors such as policy interventions, infrastructure development, foreign direct investments (FDI), improved manufacturing capabilities and access to cost-effective talent pool.
Factors Determining India as an Appealing LS Destination
DemographicsIndia’s population is projected to be 1.5 billion by 2036. With current 1.4 billion population, India estimates to surpass China and house 17-18% of the global population. With this populace strength, the demand for Life Sciences Destination tends to rapidly increase.
Industrial
Hospital industry estimated to reach USD 132 billion by 2023 with a robust 17% CAGR growth from 2017 to 2023.
Medical tourism industry expected to reach USD 13 billion by 2026, more than doubling from the 2020 figure.
Policy Push
PLI scheme allocates USD 3 billion+ for pharmaceuticals, bulk drugs and medical device segments from 2021-26.
Proposal for 7 bulk drugs & medical device parks, each with a USD 122 million and USD 12 million cap respectively will contribute to the enhancement of LS Destinations.
Healthcare Needs
With the targeted healthcare expenditure at 2.5% of GDP by FY 2025-26, the indicators project a need for 1.3 billion sq. ft. additional healthcare space by 2030 and 2.9 million more hospital beds to align with global averages in LS business parks.
Our Leadership
Ram Chandnani
Managing Director, Advisory & Transaction Services, India
Rami Kaushal
Managing Director Consulting & Valuation Services, India, Middle East & Africa
Alok Puri
Associate Executive Director, Head of Business Development & Alternate Assets, Consulting & Valuation, India
Contact Us
Share a few details about your request to get started with our team.
Share a few details about your request to get started with our team.
Life Sciences Occupier Services
Real estate to create better outcomes for your life sciences business.
Occupier services that we offer are the ones that have been planned along the lines of our core facilities. Our life sciences solutions support facilities, labs, manufacturing space and critical environments for various companies. We’ve partnered with set-ups, including the pharmaceutical industry, contract research organizations (CROs), biotech firms, contract manufacturing organizations (CMOs), medical device companies and the genomics industry.
Core Values of Our Solutions
We understand the critical nature of your portfolio and prioritize quality, compliance, health and safety in everything we do.
- Quality & Compliance: CBRE always keeps clients inspection-ready through client quality teams, a global network of life sciences quality experts and standardized GxP-compliant processes and technologies.
- Health & Safety: We know the complexities of life sciences research and manufacturing. We rely on a strong safety program to ensure our people operate safely and our clients and visitors work in safe and healthy environments.
Advisory & Transaction
We provide top-notch specialized market experts focused on life sciences, we offer industry-leading market intelligence specific to the property types that drive life sciences occupancy, including research and regulated manufacturing spaces. Our transactions experts use the CBRE network to connect life sciences buyers, sellers, tenants, and landlords with the best opportunities available in the market.
Project & Program Management
Our dedicated project management team provides the talent and tools to optimize your capital investments. As the leading global projects and capital program management firm, our engineers and construction managers are trained to support technical lab and manufacturing projects. Their core work also deals with reducing costs and delivering exceptional quality projects on time. The teams leverage proven processes and technologies to manage complex lab equipment and production system installations.
Integrated Facilities Management
We offer extensive global expertise across all facility types and deliver a range of integrated, technology-driven asset lifecycle management and employee experience solutions across labs, manufacturing space and critical environments. With robust capabilities in the GxP-regulated environment, our teams support central utility plant operations, clean room maintenance, purified water systems, gas processing, fume hoods, biosafety cabinets and other regulated or critical systems, along with more typical services.
Our Leadership
Ram Chandnani
Managing Director, Advisory & Transaction Services, India
Rami Kaushal
Managing Director Consulting & Valuation Services, India, Middle East & Africa
Alok Puri
Associate Executive Director, Head of Business Development & Alternate Assets, Consulting & Valuation, India